Treatments and Care
At the Susan and Leonard Feinstein IBD Clinical Center, we are dedicated to the treatment of the entire patient; we believe strongly in an integrative care model. You are much more than your disease. In addition to IBD specialists, we incorporate nutritionists, psychologists and social services into your care to help you develop a comprehensive treatment plan. We also involve your family – your caregivers – so everyone is invested in your treatment.
Your multi-dimensional treatment can include the following areas/disciplines:
- Medicinal Treatment: Your consultation with one of our IBD specialists will provide you an overview and recommendations for medical treatment. If you and your doctor determine that you would benefit from one of the biologic agents offered by the IBD Center, we provide both the medical treatment and monitoring services for our patients. Our state of the art infusion center provides a comfortable, private setting at which you will receive a full-range of biologic, and cutting-edge therapies.
- Clinical Trials: One of the greatest advantages of being treated at the Feinstein IBD Center is that virtually every new therapy has been developed and tried out at Mount Sinai. You will have access to the latest clinical trials and can have the option to participate in research on novel therapies that are advancing care in IBD. We encourage you to discuss your willingness to participate in a clinical trial with your doctor and to view a list of the current IBD trials.
- Surgical Consultation: Sometimes surgery may be the best treatment option for certain patients. The Feinstein IBD Center provides direct consultation with surgeons specialized in the latest surgical approaches and techniques for IBD patients. We partner with a network of highly experienced IBD surgeons including a group that sees patients directly in the Feinstein IBD Center. For patients who may have a permanent or temporary ostomy, we also have a highly experienced ostomy nurse who can provide support and specialized care.
- Nutrition: Nutrition plays a critical part of our patients’ well-being and healing, particularly those with IBD. That is why we have a Registered Dieticians (RDs) on staff at the IBD Center. An RD completes a thorough review with your medical team, reviews your current nutritional health and intake and provides a personalized treatment plan to manage your medical issues. Our staff RDs are seasoned professionals who specialize in the care of patients with IBD, irritable bowel syndrome (IBS), short bowel syndrome, celiac disease and an array of gastrointestinal illnesses. In addition, educational materials that will help you manage your current symptoms and prevent deficiencies that can often occur with IBD are available. In addition, the Feinstein IBD Center also has a gastroenterologist who specializes in advanced nutrition who is available for consultation as well.
- Mental Health Services: Your wellness and treatment depend not just on how your medical plan, but also on your overall mental well-being. At the Feinsten IBD Center, we have one of the country’s only clinical psychologists specializing in patients with gastrointestinal disease, in particular IBD. Counseling services centered on mental health, stress reduction, mind-gut interaction and building coping and resilience skills are available to our patients who may need them.
- Social and Care Coordination Support: Our social work team and clinical support staff will help you with insurance benefit guidance and navigating obstacles to your care. If you’ve had to stay in the hospital, we help arrange your transition from inpatient to outpatient/home care through the Visiting Nurse Services and other outpatient services. We provide disability guidance and assist in navigating prescription patient assistance programs. And finally, we know that caring for a loved one with IBD can be difficult on the caregiver as well so we provide support and resources for your entire care team.
At the Feinstein IBD Clinical Center we believe that early, effective intervention based on a patient’s risk of disease progression is the key to improving our patients’ quality of life and limiting the risk of complications. IBD is a progressive disease and treatment is now shifting to an early intervention approach. Emerging evidence suggests that there may be a “window of opportunity” early in the course of IBD during which treatment is most effective and can decrease the chance of serious, longer-term complications. The most effective medications, specifically anti-tumor necrosis alpha (anti-TNF) agents such as infliximab and adalimumab, work better when used earlier in the disease course during this “window of opportunity.” Clinical trials have shown that patients who were treated within one to two years of diagnosis (defined as an early approach) were lmore likely to have their disease in remission. In addition, IBD patients treated early are at decreased risk of hospitalizations, surgeries, or disease-related complications over a two-year period.